Age-dependent impact of medication underuse and strategies for improvement

Gerontology

Volumn 62, Issue 5, 2016, Pages 491-499

  Meid, Andreas D ^a   Haefeli, Walter E ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cardiovascular disease; Medication underuse; Potentially inappropriate prescribing; Public health impact

Indexed keywords

CARDIOVASCULAR AGENT;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL OUTCOME; CONTROLLED STUDY; DRUG USE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICATION UNDERUSE; MIDDLE AGED; PHARMACEUTICAL CARE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; RISK REDUCTION; SECONDARY PREVENTION; VERY ELDERLY; FEMALE; GERMANY; HEALTH SERVICE; MALE; MEDICATION THERAPY MANAGEMENT; ORGANIZATION AND MANAGEMENT; PREVENTION AND CONTROL; PROCEDURES; RISK ASSESSMENT; STANDARDS; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; FEMALE; GERMANY; HEALTH SERVICES MISUSE; HUMANS; MALE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; RISK ASSESSMENT; SECONDARY PREVENTION;

EID: 84957610507     PISSN: 0304324X     EISSN: 14230003     Source Type: Journal    
DOI: 10.1159/000443477     Document Type: Article

References (40)

1. Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging 2012; 29: 463-475
2. Heisler M, Choi H, Rosen AB, Vijan S, Kabeto M, Langa KM, Piette JD. Hospitalizations and deaths among adults with cardiovascular disease who underuse medications because of cost: a longitudinal analysis. Med Care 2010; 48: 87-94
3. Hayward RA, Asch SM, Hogan MM, Hofer TP, Kerr EA. Sins of omission: getting too little medical care may be the greatest threat to patient safety. J Gen Intern Med 2005; 20: 686-691
4. Barry AR, Loewen PS, De Lemos J, Lee KG. Reasons for non-use of proven pharmacotherapeutic interventions: systematic review and framework development. J Eval Clin Pract 2012; 18: 49-55
5. Gallagher P, Ryan C, Byrne S, Kennedy J, O Mahony D. STOPP (Screening Tool of Older Person s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 2008; 46: 72-83
6. O Mahony D, O Sullivan D, Byrne S, O Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 2015; 44: 213-218
7. Welch HG, Albertsen PC, Nease RF, Bubolz TA, Wasson JH. Estimating treatment benefits for the elderly: the effect of competing risks. Ann Intern Med 1996; 124: 577-584
8. Irving G. Cardiovascular disease and cancer compete for the outcome of death. BMJ 2014; 349:g5227
9. Meid AD, Quinzler R, Freigofas J, Saum KU, Schottker B, Holleczek B, Heider D, Konig HH, Brenner H, Haefeli WE. Medication underuse in aging outpatients with cardiovascular disease: prevalence, determinants, and outcomes in a prospective cohort study. PLoS ONE 2015; 10:e0136339
10. Meid AD, Lampert A, Burnett A, Seidling HM, Haefeli WE. The impact of pharmaceutical care interventions for medication underuse in older people: a systematic review and meta-analysis. Br J Clin Pharmacol 2015; 80: 768-776
11. Wald NJ, Morris JK. Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example. Eur J Epidemiol 2014; 29: 605-612
12. Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S, Riemer T, Senges J. Competing time-To-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis. Eur J Prev Cardiol 2014; 21: 74-80
13. Andersen PK, Geskus RB, De Witte T, Putter H. Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 2012; 41: 861-870
14. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess 2003; 7: 1-94
15. Lee S, Shafe AC, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-Trend analysis from the General Practice Research Database. BMJ Open 2011; 1:e000269
16. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 2012; 344:d8059
17. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RG, De Craen AJ, Knopp RH, Nakamura H, Ridker P, Van Domburg R, Deckers JW. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 2009; 338:b2376
18. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial Investigators. N Engl J Med 1996; 335: 1001-1009
19. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389
20. Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, Akl EA, Lansberg MG, Guyatt GH, Spencer FA; American College of Chest Physicians: Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence- Based Clinical Practice Guidelines. Chest 2012; 141:e637S-e668S.
21. R Development Core Team: R: A language and environment for statistical computing. Vienna, R Foundation for Statistical Computing, 2014
22. Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol 2011; 8: 13-28
23. Borges EP, Morgado M, Macedo AF. Prescribing omissions in elderly patients admitted to a stroke unit: descriptive study using start criteria. Int J Clin Pharm 2012; 34: 481-489
24. Papademetriou V, Farsang C, Elmfeldt D, Hofman A, Lithell H, Olofsson B, Skoog I, Trenkwalder P, Zanchetti A; Study on Cognition and Prognosis in the Elderly study group: Stroke prevention with the angiotensin II type 1-receptor blocker candesartan in elderly patients with isolated systolic hypertension: the Study on Cognition and Prognosis in the Elderly (SCOPE). J Am Coll Cardiol 2004; 44: 1175-1180
25. Bejan-Angoulvant T, Saadatian-Elahi M, Wright JM, Schron EB, Lindholm LH, Fagard R, Staessen JA, Gueyffier F. Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of randomized controlled trials. J Hypertens 2010; 28: 1366-1372
26. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117:e25-e146
27. Denardo SJ, Gong Y, Nichols WW, Messerli FH, Bavry AA, Cooper-Dehoff RM, Handberg EM, Champion A, Pepine CJ. Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an invest substudy. Am J Med 2010; 123: 719-726
28. Dodd KS, Saczynski JS, Zhao Y, Goldberg RJ, Gurwitz JH. Exclusion of older adults and women from recent trials of acute coronary syndromes. J Am Geriatr Soc 2011; 59: 506-511
29. Zaman MJ, Stirling S, Shepstone L, Ryding A, Flather M, Bachmann M, Myint PK. The association between older age and receipt of care and outcomes in patients with acute coronary syndromes: a cohort study of the Myocardial Ischaemia National Audit Project (MINAP). Eur Heart J 2014; 35: 1551-1558
30. Blom JW, De Ruijter W, Witteman JC, Assendelft WJ, Breteler MM, Hofman A, Gussekloo J. Changing prediction of mortality by systolic blood pressure with increasing age: the Rotterdam study. Age (Dordr) 2013; 35: 431-438
31. Poortvliet RK, Blom JW, De Craen AJ, Mooijaart SP, Westendorp RG, Assendelft WJ, Gussekloo J, De Ruijter W. Low blood pressure predicts increased mortality in very old age even without heart failure: the Leiden 85- plus Study. Eur J Heart Fail 2013; 15: 528-533
32. Sniderman AD, Toth PP, Thanassoulis G, Pencina MJ, Furberg CD. Taking a longer term view of cardiovascular risk: the causal exposure paradigm. BMJ 2014; 348:g3047
33. Andrawes WF, Bussy C, Belmin J. Prevention of cardiovascular events in elderly people. Drugs Aging 2005; 22: 859-876
34. Wald NJ, Oppenheimer P. Discounting the value of life. J Med Screen 2011; 18: 1
35. Cerreta F, Eichler HG, Rasi G. Drug policy for an aging population - the European Medicines Agency s geriatric medicines strategy. N Engl J Med 2012; 367: 1972-1974
36. Jin H, Tang C, Wei Q, Chen L, Sun Q, Ma G, Liu N. Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge. BMC Cardiovasc Disord 2014; 14: 127
37. Conroy RM, Pyorala K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetiere P, Jousilahti P, Keil U, Njolstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE project group: Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003
38. Appleton SC, Abel GA, Payne RA. Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study. BMC Fam Pract 2014; 15: 58
39. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Br J Clin Pharmacol 2014; 77: 1073-1082
40. Strandberg TE, Kolehmainen L, Vuorio A. Evaluation and treatment of older patients with hypercholesterolemia: a clinical review. JAMA 2014; 312: 1136-1144